US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jan 2, 2019 (8 years ago)

Cefdinir for Oral Suspension USP, 125mg/5mL, packaged in a) 60mL (NDC 68180-722-20)…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Product complaints received indicating reconstituted suspension was observed to be thick.

What was recalled

Cefdinir for Oral Suspension USP, 125mg/5mL, packaged in a) 60mL (NDC 68180-722-20), b)100mL (NDC 68180-722-10), Rx Only, Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, MD 21202; Manufactured by: Lupin Limited Mandideep 462 046 INDIA

Recalling firm
Lupin Pharmaceuticals Inc.
NDC code
68180-722-20
Origin
MD, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0375-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Cefdinir recalls

See all